Guven, Z. T. Et Al. 2023. Clofarabine, cyclophosphamide, and etoposide (CLOVE) in adult patients with relapsed/refractory acute T-cell lymphoblastic leukemia: single-center experience. CUKUROVA MEDICAL JOURNAL , vol.48, no.2 , 535-540.

Guven, Z. T., Tubay, Ş. E., Celik, S., Keklik, M., & Ünal, A., (2023). Clofarabine, cyclophosphamide, and etoposide (CLOVE) in adult patients with relapsed/refractory acute T-cell lymphoblastic leukemia: single-center experience. CUKUROVA MEDICAL JOURNAL , vol.48, no.2, 535-540.

Guven, Zeynep Et Al. "Clofarabine, cyclophosphamide, and etoposide (CLOVE) in adult patients with relapsed/refractory acute T-cell lymphoblastic leukemia: single-center experience," CUKUROVA MEDICAL JOURNAL , vol.48, no.2, 535-540, 2023

Guven, Zeynep T. Et Al. "Clofarabine, cyclophosphamide, and etoposide (CLOVE) in adult patients with relapsed/refractory acute T-cell lymphoblastic leukemia: single-center experience." CUKUROVA MEDICAL JOURNAL , vol.48, no.2, pp.535-540, 2023

Guven, Z. T. Et Al. (2023) . "Clofarabine, cyclophosphamide, and etoposide (CLOVE) in adult patients with relapsed/refractory acute T-cell lymphoblastic leukemia: single-center experience." CUKUROVA MEDICAL JOURNAL , vol.48, no.2, pp.535-540.

@article{article, author={Zeynep Tugba Guven Et Al. }, title={Clofarabine, cyclophosphamide, and etoposide (CLOVE) in adult patients with relapsed/refractory acute T-cell lymphoblastic leukemia: single-center experience}, journal={CUKUROVA MEDICAL JOURNAL}, year=2023, pages={535-540} }